Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Sihua Lan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2850-3764; OpenAlex author ID A5091816284. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. Erratum to "tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targeting ASCL2" [GENE 927C (2024) 148739]. Co-author DOI 10.1016/j.gene.2024.148909↗
  2. tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targeting ASCL2. Co-author DOI 10.1016/j.gene.2024.148739↗
  3. Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of PPM1K in the Tumor Microenvironment. First author DOI 10.3390/cancers15020474↗
  4. METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fcell.2022.759020↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shineng Zhang · 4 shared papers, 2022–2025 · strength 0.91
  2. Yanyan Zhuang · 4 shared papers, 2022–2025 · strength 0.91
  3. Juanfei Peng · 2 shared papers, 2022–2023 · strength 0.38
  4. Fengting Huang · 2 shared papers, 2022–2023 · strength 0.38
  5. Dandan Zheng · 1 shared paper, 2025 · strength 0.28
  6. Wa Zhong · 1 shared paper, 2023 · strength 0.22
  7. Liting Lu · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.